Acute modulation of myocardial function by angiotensin 1–7

Averill, 2003, Cardiac angiotensin-(1–7) in ischemic cardiomyopathy, Circulation, 108, 2141, 10.1161/01.CIR.0000092888.63239.54 Brosnihan, 1996, Angiotensin-(1–7) dilates canine coronary arteries through kinins and nitric oxide, Hypertension, 27, 523, 10.1161/01.HYP.27.3.523 Brutsaert, 1988, Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle, Circ Res, 62, 358, 10.1161/01.RES.62.2.358 Castro, 2005, Evidence for a functional interaction of the angiotensin-(1–7) receptor Mas with AT1 and AT2 receptors in the mouse heart, Hypertension, 46, 937, 10.1161/01.HYP.0000175813.04375.8a Chappell, 1998, Metabolism of angiotensin-(1–7) by angiotensin-converting enzyme, Hypertension, 31, 362, 10.1161/01.HYP.31.1.362 Crackower, 2002, Angiotensin-converting enzyme 2 is an essential regulator of heart function, Nature, 417, 822, 10.1038/nature00786 Donoghue, 2000, A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9, Circ Res, 87, E1, 10.1161/01.RES.87.5.e1 Donoghue, 2003, Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins, J Mol Cell Cardiol, 35, 1043, 10.1016/S0022-2828(03)00177-9 Ferrario, 2006, Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research, J Renin Angiotensin Aldosterone Syst, 7, 3, 10.3317/jraas.2006.003 Ferrario, 2005, Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function, Am J Physiol Heart Circ Physiol, 289, H2281, 10.1152/ajpheart.00618.2005 Gurley, 2006, Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice, J Clin Invest, 116, 2218, 10.1172/JCI16980 Iyer, 1998, Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system, Hypertension, 31, 356, 10.1161/01.HYP.31.1.356 Keidar, 2007, ACE2 of the heart: from angiotensin I to angiotensin (1–7), Cardiovasc Res, 73, 463, 10.1016/j.cardiores.2006.09.006 Kim, 2000, Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases, Pharmacol Rev, 52, 11 Leite-Moreira, 2004, Inotropic effects of ETB receptor stimulation and their modulation by endocardial endothelium, NO, and prostaglandins, Am J Physiol Heart Circ Physiol, 287, H1194, 10.1152/ajpheart.00563.2003 Leite-Moreira, 2003, ET-1 increases distensibility of acutely loaded myocardium: a novel ETA and Na+/H+ exchanger-mediated effect, Am J Physiol Heart Circ Physiol, 284, H1332, 10.1152/ajpheart.00715.2002 Mahon, 1994, Angiotensin(1–7) is an antagonist at the type 1 angiotensin II receptor, J Hypertens, 12, 1377, 10.1097/00004872-199412000-00010 Mercure, 2008, Angiotensin(1–7) blunts hypertensive cardiac remodeling by a direct effect on the heart, Circ Res, 103, 1319, 10.1161/CIRCRESAHA.108.184911 Paul, 2006, Physiology of local renin–angiotensin systems, Physiol Rev, 86, 747, 10.1152/physrev.00036.2005 Porsti, 1994, Release of nitric oxide by angiotensin-(1–7) from porcine coronary endothelium: implications for a novel angiotensin receptor, Br J Pharmacol, 111, 652, 10.1111/j.1476-5381.1994.tb14787.x Ren, 2002, Vasodilator action of angiotensin-(1–7) on isolated rabbit afferent arterioles, Hypertension, 39, 799, 10.1161/hy0302.104673 Rowe, 1995, Angiotensin-(1–7) binding at angiotensin II receptors in the rat brain, Regul Pept, 56, 139, 10.1016/0167-0115(95)00010-9 Sampaio, 2007, Angiotensin-(1–7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways, Hypertension, 49, 185, 10.1161/01.HYP.0000251865.35728.2f Santos, 2007, Angiotensin-(1–7) and the renin–angiotensin system, Curr Opin Nephrol Hypertens, 16, 122, 10.1097/MNH.0b013e328031f362 Santos, 2008, Recent advances in the angiotensin-converting enzyme 2-angiotensin(1–7)-Mas axis, Exp Physiol, 93, 519, 10.1113/expphysiol.2008.042002 Santos, 2003, Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas, Proc Natl Acad Sci USA, 100, 8258, 10.1073/pnas.1432869100 Schiavone, 1988, Release of vasopressin from the rat hypothalamo–neurohypophysial system by angiotensin-(1–7) heptapeptide, Proc Natl Acad Sci USA, 85, 4095, 10.1073/pnas.85.11.4095 Sys, 1998, Physiopharmacological evaluation of myocardial performance: how to study modulation by cardiac endothelium and related humoral factors?, Cardiovasc Res, 39, 136, 10.1016/S0008-6363(98)00093-5 Tipnis, 2000, A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase, J Biol Chem, 275, 33238, 10.1074/jbc.M002615200 Yamada, 1998, Converting enzyme determines plasma clearance of angiotensin-(1–7), Hypertension, 32, 496, 10.1161/01.HYP.32.3.496